Brain Aneuryms: Isn’t Time to Review the Strategy for its Detection and Screening in Limited Clinical Environment and in the New Robotic Era?

Submit Manuscript | http://medcraveonline.com Despite challenging task, a reasonable brain aneurysm visualization can be performed by noninvasive methods as magnetic resonance angiography (which identifies small aneurysms between 3 to 5 mm size) with up to 95% sensitivity and high accuracy when special sequences as volume rendering and 3D time-of-flight are performed or CT angiography which has good sensitivity for aneurysms larger than 3 mm [5]. This is making the DSA is no longer considered essential for establishing the diagnostic of brain aneurysms [1]. Non-invasive methods are particularly recognised for screening of the highrisk brain aneurysmal populations e.g patients with genetic or collagen diseases, familiar occurrence or with history of multiple aneurysms or “minor” neurological symptoms including e.g chronic or recent headache or migraines like headache, visual acuity loss, cranial neuropathies, pyramidal tract dysfunction, pituitary clinical manifestations, atypical facial pain among others. Also, it has been used specially angioCT as routine after subarachnoid haemorrhage or follow-up of treated brain aneurysm [7-15].